Akari TherapeuticsAKTX
13F holders, Q1 2024 (March 31)8holders
1famous investor
$1.87avg. 13F price*
At the end of Q1 2024, 8 institutions reported holding Akari Therapeutics PLC (AKTX) in their 13F filings. The largest holders were Omnia Family Wealth, LLC ($163K), Sabby Management, LLC ($90K) and Cerity Partners LLC ($44K). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Akari Therapeutics PLC
- CUSIP
- 00972G207
- Latest filing quarter
- Q1 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $90K |
| Exits | 1 | $22 |
Ownership 8 holders
| Omnia Family Wealth, LLC | 0.08% | No change | 87,628 | $163K |
| Sabby Management, LLC | 0.65% | New | 48,491 | $90K |
| Cerity Partners LLC | 0.00% | No change | 23,643 | $44K |
| Renaissance Technologies | 0.00% | Add +43.8% | 14,769 | $28K |
| Bank of America Corp. | 0.00% | No change | 150 | $280 |
| Truvestments Capital LLC | 0.00% | No change | 50 | $93 |
| Morgan Stanley | 0.00% | Reduce -25.0% | 6 | $11 |
| Cornerstone Planning Group LLC | 0.00% | New | 5 | $7 |
"% of holder's portfolio" is AKTX's weight in each manager's 13F, not the share of Akari Therapeutics PLC the manager owns.